EN
HI
Summary
As of 19 Sep, 2026, Caplin Point Laboratories stock price is ₹2748.6. During the trading session, the stock has moved between an intraday low of ₹2596.00 and an intraday high of ₹2780.00. Over the last 52 weeks, Caplin Point Laboratories has traded between ₹1500.30 and ₹2877.30.
The stock has recorded a trading volume of 3,08,471 shares,. Its Average Traded Price (ATP) is ₹2719.30, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2748.60.
Caplin Point Laboratories has an upper circuit limit of ₹3298.30 and a lower circuit limit of ₹2198.90. The total value traded stands at ₹83.88 CR, and the delivery percentage for the day is 30.83%.
The stock is currently traded with a market lot size of 1. Caplin Point Laboratories also offers a dividend yield of 0.29%.
Caplin Point Laboratories Share Price Chart
Caplin Point Laboratories Share Key Metrics
Volume
3.08 L
Market Cap
20892.57 CR
LTQ@LTP
2@2748.60
ATP
2719.3
Var Margin
18.98 %
Circuit Range
2198.9-3298.3
Delivery %
30.83 %
Value
83.88 CR
ASM/GSM
No
Market Lot
1
Caplin Point Laboratories Fundamentals
P/E Ratio
31.39
P/B Ratio
5.69
Div. Yield
0.29
Sector P/E
42.35
Sector P/B
3.6
Sec. Div. Yield
0.51
Caplin Point Laboratories Resistance and Support
Pivot 2601.9
Resistance
First Resistance
2624.5
Second Resistance
2652.4
Third Resistance
2675
Support
First Support
2574
Second Support
2551.4
Third Support
2523.5
Caplin Point Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 2596.5 | 2748.6 | 5.85% | 2780 | 2596 |
| Thu Sep 17 2026 | 2586.6 | 2596.6 | 0.53% | 2629.8 | 2579.3 |
| Wed Sep 16 2026 | 2581 | 2583 | 0.48% | 2606.69 | 2490.5 |
Caplin Point Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-12 | Quarterly Results & Final Dividend |
| 2026-05-14 | Audited Results & Interim Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-15 | Audited Results & Interim Dividend |
| 2025-02-07 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-07 | Quarterly Results & Final Dividend |
Caplin Point Laboratories News
Caplin Point Laboratories Ltd - 524742 - General Updates
Caplin Point's subsidiary, Caplin One Labs Limited (COL), received Good Manufacturing Practices (GMP) compliance certification from Colombia's INVIMA for its manufacturing unit in Tamil Nadu, India. This certification allows COL to manufacture and export oncology drug products to Colombia.
Sep 01 2026 18:04:28
Caplin Point Laboratories Ltd - 524742 - General Updates
Caplin Point's subsidiary, Caplin Steriles Limited, completed an unannounced US FDA inspection at its injectable and ophthalmic manufacturing facility. The company received 10 procedural Form 483 observations, which are not related to data integrity or repeat findings.
Aug 21 2026 19:07:36
Caplin Point Laboratories Management
| Name | Position |
|---|---|
| G Venkatram | General Counsel & Company Secretary, Compliance Officer |
| C C Paarthipan | Chairman |
Caplin Point Laboratories Similar Stocks
Rubicon Research Ltd.
1751.10
-27.20 (1.53%)
Neuland Laboratories Ltd.
22840.00
175.00 (0.77%)
Acutaas Chemicals Ltd.
3440.30
125.20 (3.78%)
Piramal Pharma Ltd.
208.16
3.45 (1.69%)
Granules India Ltd.
875.50
5.10 (0.59%)
Astrazeneca Pharma India Ltd.
6751.50
82.50 (1.24%)
Pfizer Ltd.
4002.40
-12.40 (0.31%)
Onesource Specialty Pharma Ltd.
1594.90
14.90 (0.94%)
Shilpa Medicare Ltd.
1021.10
62.75 (6.55%)
Eris Lifesciences Ltd.
1321.30
10.60 (0.81%)
Caplin Point Laboratories FAQs
The Buying Price of Caplin Point Laboratories share is 2748.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Caplin Point Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Caplin Point Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Caplin Point Laboratories shares is 31.39. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Caplin Point Laboratories shares is 5.69. Useful to assess the stock's value relative to its book value.
To assess Caplin Point Laboratories’s valuation compare Sector P/E, P/B which are 42.35 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Caplin Point Laboratories is 20892.57 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Caplin Point Laboratories share price is 2877.30 & 1500.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Caplin Point Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CAPLIPOINT
Or Download Choice FinX App
Invest in CAPLIPOINT
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade